Literature DB >> 15550055

Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma.

J Thom, G Gilmore, Q Yi, G J Hankey, J W Eikelboom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550055     DOI: 10.1111/j.1538-7836.2004.00962.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  10 in total

Review 1.  CD40/CD40L system and vascular disease.

Authors:  F Santilli; S Basili; P Ferroni; G Davì
Journal:  Intern Emerg Med       Date:  2007-11-28       Impact factor: 3.397

2.  Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.

Authors:  Vanessa Valdes; Michael A Nardi; Lindsay Elbaum; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

3.  Increased serum levels of interleukin-6 and von Willenbrand Factor in early phase of acute coronary syndrome in a young and multiethnic Malaysian population.

Authors:  Wen Ni Tiong; Alan Yean Yip Fong; Edmund Ui Hang Sim; Hiang Chuan Chan; Tiong Kiam Ong; Boon Cheng Chang; Kui Hian Sim
Journal:  Heart Asia       Date:  2012-10-16

4.  Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16.

Authors:  Benjamin A Olenchock; Stephen D Wiviott; Sabina A Murphy; Christopher P Cannon; Nader Rifai; Eugene Braunwald; David A Morrow
Journal:  J Thromb Thrombolysis       Date:  2007-10-05       Impact factor: 2.300

5.  Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Authors:  David A Morrow; Marc S Sabatine; Marie-Luise Brennan; James A de Lemos; Sabina A Murphy; Christian T Ruff; Nader Rifai; Christopher P Cannon; Stanley L Hazen
Journal:  Eur Heart J       Date:  2008-03-12       Impact factor: 29.983

6.  Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study.

Authors:  John F Keaney; Izabella Lipinska; Martin G Larson; Josée Dupuis; Jane E Freedman; Naomi M Hamburg; Joseph M Massaro; Jian Rong; Patrice Sutherland; Joseph A Vita; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Am Heart J       Date:  2008-10-02       Impact factor: 4.749

7.  Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy.

Authors:  Efthymios Arvanitidis; Sergio Bizzarro; Elena Alvarez Rodriguez; Bruno G Loos; Elena A Nicu
Journal:  Thromb J       Date:  2017-02-06

8.  Is delayed pressure urticaria associated with increased systemic release of sCD40L?

Authors:  T Jasinska; A Grzanka; E Machura; A Kasperska-Zajac
Journal:  Biomed Res Int       Date:  2013-10-23       Impact factor: 3.411

9.  New frontiers for platelet CD154.

Authors:  Antoine Dewitte; Annabelle Tanga; Julien Villeneuve; Sébastien Lepreux; Alexandre Ouattara; Alexis Desmoulière; Christian Combe; Jean Ripoche
Journal:  Exp Hematol Oncol       Date:  2015-03-01

Review 10.  The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

Authors:  Laura A Bosmans; Lena Bosch; Pascal J H Kusters; Esther Lutgens; Tom T P Seijkens
Journal:  J Cardiovasc Transl Res       Date:  2020-03-28       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.